Solved: Cure all Inc has developed a drug that will diminish

the

Cure-all, Inc., has developed a drug that will diminish the effects of aging. Cure-all has spent
$1,000,000 on research and development and $2,108,000 for clinical trials. Once the drug is
approved by the FDA, which is imminent, it will have a five-year sales life cycle. Laura Russell,
Cure-all’s chief financial officer, must determine the best alternative for the company among
three options. The company can choose to manufacture, package, and distribute the drug;
outsource only the manufacturing; or sell the drug’s patent. Laura has compiled the following
annual cost information for this drug if the company were to manufacture it:

Management anticipates a high demand for the drug and has benchmarked $235 per unit as a
reasonable price based on other drugs that promise similar results. Management expects sales
volume of 3,000,000 units over five years and uses a discount rate of 10 percent. If Cure-all
chooses to outsource the manufacturing of the drug while continuing to package, distribute, and
advertise it, the manufacturing costs would result in fixed costs of $1,500,000 and variable cost
per unit of $80. For the sale of the patent, Cure-all would receive $300,000,000 now and
$25,000,000 at the end of every year for the next five years.

Required
Determine the best option for Cure-all. Support youranswer.

ANSWER
https://solvedquest.com/cure-all-inc-has-developed-a-drug-that-will-diminish-the/

Reach out to freelance2040@yahoo.com for enquiry.

Powered by TCPDF (www.tcpdf.org)